Multipayer Primary Care Transformation: Impact for Medicaid Managed Care Beneficiaries
November 21st 2019The Michigan Primary Care Transformation project generated cost savings among adults in Medicaid managed care, particularly high-risk adults, while largely maintaining quality of care.
Importance of Reasons for Stocking Adult Vaccines
November 20th 2019Economic factors associated with the purchase and maintenance of vaccine inventory and inadequate reimbursement for vaccination services were the most important to pharmacy and doctors’ office decision makers when considering whether to stock adult vaccines.
Prescribing Trend of Pioglitazone After Safety Warning Release in Korea
November 19th 2019The pioglitazone safety warning issued in South Korea, which recommended prescribing with careful attention among those with high risk of bladder cancer, led to a moderate decrease in pioglitazone users.
Cost Analysis of COPD Exacerbations and Cardiovascular Events in SUMMIT
November 18th 2019This cost analysis using data from the Study to Understand Mortality and Morbidity in COPD (SUMMIT) trial found that fluticasone furoate/vilanterol reduced the rates and costs of combined chronic obstructive pulmonary disease (COPD) exacerbations and revascularization/cardiovascular events versus placebo.
Multimodality Cancer Care and Implications for Episode-Based Payments in Cancer
November 12th 2019Most patients receiving multimodality cancer care receive care from different practices. Therefore, episode-based payments in oncology must hold multiple providers accountable for costs and quality.
CKD Quality Improvement Intervention With PCMH Integration: Health Plan Results
November 8th 2019A scalable chronic kidney disease (CKD) quality improvement intervention demonstrated feasibility, decreased hospitalization, and reduced costs. These preliminary results support innovation in CKD by commercial health plans.